EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.
J Immunol
; 192(3): 859-66, 2014 Feb 01.
Article
in En
| MEDLINE
| ID: mdl-24337738
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin
/
Interleukin-6
/
Interleukin-17
/
Dermatitis, Atopic
/
Epidermal Growth Factor
/
Th17 Cells
/
ErbB Receptors
Type of study:
Etiology_studies
/
Prognostic_studies
Language:
En
Journal:
J Immunol
Year:
2014
Type:
Article